References

Adlington H, Cumberbatch G Carotid sinus massage: is it a safe way to terminate supraventricular tachycardia?. Emerg Med J. 2009; 26:(6) https://doi.org/10.1136/emj.2008.062968

Appelboam A, Reuben A, Mann C Randomised evaluation of modified Valsalva effectiveness in re-entrant tachycardias (REVERT) study. BMJ Open. 2014; 4:(3) https://doi.org/10.1136/bmjopen-2013-004525

Bridgwater: Class Professional Publishing; 2013

Cabalag MS, Taylor DM, Knott JC, Buntine P, Smit D, Meyer A Recent caffeine ingestion reduces adenosine efficacy in the treatment of paroxysmal supraventricular tachycardia. Acad Emerg Med. 2010; 17:(1)44-9 https://doi.org/10.1111/j.1553-2712.2009.00616.x

Critical Appraisal Skills Programme. 2013. http//www.casp-uk.net/#!casp-tools-checklists/c18f8 (accessed 25 November 2015)

Fogoros RN, 5th edn. Chichester: Wiley-Blackwell; 2012

Furlong R, Gerhardt RT, Farber P, Schrank K, Willig R, Pittaluga J Intravenous adenosine as first-line pre-hospital management of narrow-complex tachycardias by EMS personnel without direct physician control. Am J Emerg Med. 1995; 13:(4)383-8 https://doi.org/10.1016/0735-6757(95)90119-1

Gausche M, Persse DE, Sugarman T Adenosine for the prehospital treatment of paroxysmal supraventricular tachycardia. Ann Emerg Med. 1994; 24:(2)183-9 https://doi.org/10.1016/S0196-0644(94)70128-8

Gill BU, Bukhari SN, Rashid MA, Saleemi MS, Zaffar MZ Comparing the efficacy of intravenous adenosine and verapamil in termination of acute paroxysmal supraventricular tachycardia. J Ayub Med Coll Abbottabad. 2014; 26:(1)29-31

Goebel PJ, Daya MR, Gunnels MD Accuracy of arrhythmia recognition in paramedic treatment of paroxysmal supraventricular tachycardia. Prehosp Emerg Care. 2004; 8:(2)166-70 https://doi.org/10.1080/312703004271

Hale P, Lowe R, Seamon JP, Jenkins JJ Paramedic Electrocardiogram and Rhythm Identification: A Convenient Training Device. Prehosp Disaster Med. 2011; 26:(5)342-5 https://doi.org/10.1017/S1049023X11006558

Hamer S, Collinson G, 2nd edn. London: Elsevier; 2005

Haynes BE Two deaths after pre-hospital use of adenosine. J Emerg Med. 2001; 21:(2)151-4 https://doi.org/10.1016/S0736-4679(01)00358-4

Lim SH, Anantharaman V, Teo WS, Goh PP, Tan AT Comparison of treatment of supraventricular tachycardia by Valsalva maneuver and carotid sinus massage. Ann Emerg Med. 1998; 31:(1)30-5 https://doi.org/10.1016/S0196-0644(98)70277-X

Lozano M, McIntosh BA, Giordano LM Effect of adenosine on the management of supraventricular tachycardia by urban paramedics. Ann Emerg Med. 1995; 26:(6)691-6 https://doi.org/10.1016/S0196-0644(95)70039-0

Mallet ML Proarrhythmic effects of adenosine: a review of the literature. Emerg Med J. 2004; 21:(4)408-10 https://doi.org/10.1136/emj.2004.016048

McCabe JL, Adhar GC, Menegazzi JJ, Paris PM Intravenous adenosine in the prehospital treatment of paroxysmal supraventricular tachycardia. Ann Emerg Med. 1992; 21:(4)358-61 https://doi.org/10.1016/S0196-0644(05)82650-2

Mehta D, Wafa S, Ward DE, Camm AJ Relative efficacy of various physical manoeuvres in the termination of junctional tachycardia. Lancet. 1988; 1:(8596)1181-5 https://doi.org/10.1016/S0140-6736(88)92008-9

Morrison LJ, Allan R, Vermeulen M, Dong SL, McCallum AL Conversion rates for prehospital paroxysmal supraventricular tachycardia (PSVT) with the addition of adenosine: a before-and-after trial. Prehosp Emerg Care. 2001; 5:(4)353-9 https://doi.org/10.1080/10903120190939508

O'Rourke SF, Sauvage A, Evans PA Paroxysmal supraventricular tachycardia: improving diagnosis and management within the accident and emergency department. Emerg Med J. 2004; 21:(4)495-7 https://doi.org/10.1136/emj.2003.012054

Orejarena LA, Vidaillet H, DeStefano F Paroxysmal supraventricular tachycardia in the general population. J Am Coll Cardiol. 1998; 31:(1)150-7 https://doi.org/10.1016/S0735-1097(97)00422-1

Resuscitation Council (UK). 2010. http//www.resus.org.uk/pages/tachpost.pdf (accessed 24 November)

, 6th edn. London: Resuscitation Council (UK); 2011

Riccardi A, Arboscello E, Ghinatti M, Minuto P, Lerza R Adenosine in the treatment of supraventricular tachycardia 5 years of experience (2002-2006). Am J Emerg Med. 2008; 26:(8)879-82 https://doi.org/10.1016/j.ajem.2007.11.029

Sawhney V, Corden B, Abdul-Mukith K, Harris T, Schilling RJ Area patients admitted to emergency departments with regular supraventricular tachycardia (SVT) treated appropriately?. Clin Med. 2013; 13:(2)146-8 https://doi.org/10.7861/clinmedicine.13-2-146

Smith G, Boyle MJ The 10 ml syringe in generating the recommended standard of 40 mmHg intrathoracic pressure for the Valsalva manoeuvre. Emerg Med Australas. 2009; 21:(6)449-54 https://doi.org/10.1111/j.1742-6723.2009.01228.x

Smith G, Broek A, McD Taylor D, Morgans A, Cameron P Identification of the optimum vagal manoeuvre technique for maximising vagal tone. Emerg Med J. 2014b; 32:(1)51-4 https://doi.org/10.1136/emermed-2013-203299

Smith G, McD Taylor D, Morgans A, Cameron P Prehospital management of supraventricular tachycardia in Victoria, Australia: epidemiology and effectiveness of therapies. Emerg Med Australas. 2014a; 26:(4)350-5 https://doi.org/10.1111/1742-6723.12248

Smith G, McD Taylor D, Morgans A, Cameron P Measuring the effectiveness of a revised clinical practice guideline for the pre-hospital management of supraventricular tachycardia. Emerg Med Australas. 2015; 27:(1)22-8 https://doi.org/10.1111/1742-6723.12340

Smith G, Morgans A, Boyle M Use of the Valsalva manoeuvre in the prehospital setting: a review of the literature. Emerg Med J. 2009; 26:(1)8-10 https://doi.org/10.1136/emj.2008.061572

Swift J Assessment and treatment of patients with acute tachyarrhythmia. Nurs Stand. 2013; 28:(5)50-59 https://doi.org/10.7748/ns2013.10.28.5.50.e7210

Walker S, Cutting P Impact of a modified Valsalva manoeuvre in the terminal of paroxysmal supraventricular tachycardia. Emerg Med J. 2010; 27:(4)287-91 https://doi.org/10.1136/emj.2009.073866

Wen ZC, Chen SA, Tai CT, Chiang CE, Chiou CW, Chang MS Electrophysiological mechanisms and determinants of vagal maneuvers for termination of paroxysmal supraventricular tachycardia. Circulation. 1998; 98:(24)2716-23 https://doi.org/10.1161/01.CIR.98.24.2716

Whinnet ZI, Sohaib SMA, Davies DW Diagnosis and management of Supraventricular tachycardia. BMJ. 2012; 345 https://doi.org/10.1136/bmj.e776

Wittwer LK, Muhr MC Adenosine for the treatment of PSVT in the prehospital arena: efficacy of an initial 6 mg dosing regimen. Prehosp Disaster Med. 1997; 12:(3)237-9 https://doi.org/10.1017/S1049023X00037663

Pre-hospital treatment of supraventricular tachycardia: a literature review

02 December 2015
Volume 7 · Issue 12

Abstract

Background:

Tachycardia is a common finding within the unwell patient and can occur as a normal physiological response or as a result of an underlying arrhythmia. Supraventricular tachycardia (SVT) is a common cardiac arrhythmia which can be treated through a range of differing techniques. The aim of this review was to identify whether the current evidence base supports UK paramedic practice and whether the treatment provided could be enhanced.

Methods:

A literature review through the databases CINAHL, Pubmed and Medline was carried out, using a Boolean search strategy. Articles were included within the study if they discussed the management of SVT through the use of the Valsalva manoeuvre, carotid sinus massage or adenosine within the hospital or pre-hospital environment.

Results:

A total of 32 papers were identified for possible inclusion, with 18 papers being included. The Valsalva manoeuvre was shown to be the most effective vagal manoeuvre, with reversion rates of 21.4–27.7% within the pre-hospital environment. The use of adenosine was shown to be effective in reverting SVT, with most total reversion rates being 80.7–100%. The initial 6 mg dose was shown to have lower efficacy than the subsequent 12 mg doses. Correct paramedic identification rates of SVT were greater than 75%.

Conclusions:

The Valsalva manoeuvre has been shown to be effective and potentially more effective the quicker it is used following onset of the SVT. The safe use of adenosine by paramedics within the US and Australia support the introduction of adenosine into UK paramedic practice.

Paramedics are often the first point of call for acutely unwell patients who present with a tachycardia. This tachycardia can be a natural physiological response, or less frequently, an underlying cardiac arrhythmia. Swift (2013) defines a tachyarrhythmia as: ‘where the pulse rate is greater than 100 beats per minute (bpm), with abnormal cardiac conduction present.’

Supraventricular tachycardia (SVT) is a common cardiac tachyarrhythmia that has a prevalence of 2.29 per 1 000 people, with an occurrence of 35 out of 100 000 person-years (Orejarena et al, 1998). SVT is a transient narrow complex tachyarrhythmia (Figure 1) that is associated with a pulse rate of greater than 160 bpm, but typically 180–250 bpm, with an abrupt onset of palpitations. Other common symptoms include syncope, chest pain/tightness and shortness of breath (Whinnet et al, 2012). These typically result in an emergency call to the ambulance service.

Subscribe to get full access to the Journal of Paramedic Practice

Thank you for visiting the Journal of Paramedic Practice and reading our archive of expert clinical content. If you would like to read more from the only journal dedicated to those working in emergency care, you can start your subscription today for just £48.

What's included

  • CPD Focus

  • Develop your career

  • Stay informed